Deficiency of both L-selectin and ICAM-1 exacerbates imiquimod-induced psoriasis-like skin inflammation through increased infiltration of antigen presenting cells

Clinical Immunology

Volumn 157, Issue 1, 2015, Pages 43-55

  Mitsui, Aya ^a   Tada, Yayoi ^a   Shibata, Sayaka ^a   Kamata, Masahiro ^a   Hau, Carren ^a   Asahina, Akihiko ^b   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Adhesion molecules; Cytokine; Skin

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMIQUIMOD; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 23; L SELECTIN; LIGAND; TUMOR NECROSIS FACTOR ALPHA; AMINOQUINOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; DERMATITIS; DISEASE EXACERBATION; DISEASE SEVERITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SKIN DEFECT; UPREGULATION; ANIMAL; CELL MOTION; CHEMICALLY INDUCED; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SKIN;

AMINOQUINOLINES; ANIMALS; ANTIGEN-PRESENTING CELLS; CELL MOVEMENT; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-17; L-SELECTIN; MICE; MICE, KNOCKOUT; PSORIASIS; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 84921474966     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.12.011     Document Type: Article

References (48)

1. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
2. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986, 137:245-254.
3. McEver R.P., Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J. Clin. Invest. 1997, 100:S97-S103.
4. Arbones M.L., Ord D.C., Ley K., Ratech H., Maynard-Curry C., Otten G., Capon D.J., Tedder T.F. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994, 1:247-260.
5. Tang M.L., Hale L.P., Steeber D.A., Tedder T.F. L-selectin is involved in lymphocyte migration to sites of inflammation in the skin: delayed rejection of allografts in L-selectin-deficient mice. J. Immunol. 1997, 158:5191-5199.
6. Tedder T.F., Steeber D.A., Chen A., Engel P. The selectins: vascular adhesion molecules. FASEB J. 1995, 9:866-873.
7. Xu J., Grewal I.S., Geba G.P., Flavell R.A. Impaired primary T cell responses in L-selectin-deficient mice. J. Exp. Med. 1996, 183:589-598.
8. Catalina M.D., Carroll M.C., Arizpe H., Takashima A., Estess P., Siegelman M.H. The route of antigen entry determines the requirement for L-selectin during immune responses. J. Exp. Med. 1996, 184:2341-2351.
9. Kunkel E.J., Ley K. Distinct phenotype of E-selectin-deficient mice. E-selectin is required for slow leukocyte rolling in vivo. Circ. Res. 1996, 79:1196-1204.
10. Sligh J.E., Ballantyne C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., Beaudet A.L. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8529-8533.
11. Xu H., Gonzalo J.A., St Pierre Y., Williams I.R., Kupper T.S., Cotran R.S., Springer T.A., Gutierrez-Ramos J.C. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 1994, 180:95-109.
12. Nagaoka T., Kaburagi Y., Hamaguchi Y., Hasegawa M., Takehara K., Steeber D.A., Tedder T.F., Sato S. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am. J. Pathol. 2000, 157:237-247.
13. Steeber D.A., Campbell M.A., Basit A., Ley K., Tedder T.F. Optimal selectin-mediated rolling of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7562-7567.
14. Labow M.A., Norton C.R., Rumberger J.M., Lombard-Gillooly K.M., Shuster D.J., Hubbard J., Bertko R., Knaack P.A., Terry R.W., Harbison M.L., et al. Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunity 1994, 1:709-720.
15. Bullard D.C., Kunkel E.J., Kubo H., Hicks M.J., Lorenzo I., Doyle N.A., Doerschuk C.M., Ley K., Beaudet A.L. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J. Exp. Med. 1996, 183:2329-2336.
16. Frenette P.S., Mayadas T.N., Rayburn H., Hynes R.O., Wagner D.D. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 1996, 84:563-574.
17. Kanwar S., Bullard D.C., Hickey M.J., Smith C.W., Beaudet A.L., Wolitzky B.A., Kubes P. The association between alpha4-integrin, P-selectin, and E-selectin in an allergic model of inflammation. J. Exp. Med. 1997, 185:1077-1087.
18. Schon M.P., Boehncke W.H. Psoriasis. N. Engl. J. Med. 2005, 352:1899-1912.
19. Das P.K., de Boer O.J., Visser A., Verhagen C.E., Bos J.D., Pals S.T. Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis. Acta Derm. Venereol. Suppl. (Stockh.) 1994, 186:21-22.
20. Inaoki M., Sato S., Shimada Y., Kawara S., Steeber D.A., Tedder T.F., Takehara K. Decreased expression levels of L-selectin on subsets of leucocytes and increased serum L-selectin in severe psoriasis. Clin. Exp. Immunol. 2000, 122:484-492.
21. van der Fits L., Mourits S., Voerman J.S., Kant M., Boon L., Laman J.D., Cornelissen F., Mus A.M., Florencia E., Prens E.P., Lubberts E. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 2009, 182:5836-5845.
22. Asano Y., Stawski L., Hant F., Highland K., Silver R., Szalai G., Watson D.K., Trojanowska M. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am. J. Pathol. 2010, 176:1983-1998.
23. Zaba L.C., Cardinale I., Gilleaudeau P., Sullivan-Whalen M., Suarez-Farinas M., Fuentes-Duculan J., Novitskaya I., Khatcherian A., Bluth M.J., Lowes M.A., Krueger J.G. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007, 204:3183-3194.
24. Chaudhari U., Romano P., Mulcahy L.D., Dooley L.T., Baker D.G., Gottlieb A.B. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001, 357:1842-1847.
25. Leonardi C.L., Powers J.L., Matheson R.T., Goffe B.S., Zitnik R., Wang A., Gottlieb A.B. Etanercept as monotherapy in patients with psoriasis. N. Engl. J. Med. 2003, 349:2014-2022.
26. Gottlieb A., Krueger J.G., Bright R., Ling M., Lebwohl M., Kang S., Feldman S., Spellman M., Wittkowski K., Ochs H.D., Jardieu P., Bauer R., White M., Dedrick R., Garovoy M. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J. Am. Acad. Dermatol. 2000, 42:428-435.
27. Kothary N., Diak I.L., Brinker A., Bezabeh S., Avigan M., Dal Pan G. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. J. Am. Acad. Dermatol. 2011, 65:546-551.
28. Rothlein R., Dustin M.L., Marlin S.D., Springer T.A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 1986, 137:1270-1274.
29. Yang L., Froio R.M., Sciuto T.E., Dvorak A.M., Alon R., Luscinskas F.W. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 2005, 106:584-592.
30. Marski M., Kandula S., Turner J.R., Abraham C. CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J. Immunol. 2005, 175:7889-7897.
31. Scholer A., Hugues S., Boissonnas A., Fetler L., Amigorena S. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory. Immunity 2008, 28:258-270.
32. Lowes M.A., Chamian F., Abello M.V., Fuentes-Duculan J., Lin S.L., Nussbaum R., Novitskaya I., Carbonaro H., Cardinale I., Kikuchi T., Gilleaudeau P., Sullivan-Whalen M., Wittkowski K.M., Papp K., Garovoy M., Dummer W., Steinman R.M., Krueger J.G. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19057-19062.
33. Pendl G.G., Robert C., Steinert M., Thanos R., Eytner R., Borges E., Wild M.K., Lowe J.B., Fuhlbrigge R.C., Kupper T.S., Vestweber D., Grabbe S. Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1. Blood 2002, 99:946-956.
34. Dudda J.C., Simon J.C., Martin S. Dendritic cell immunization route determines CD8+ T cell trafficking to inflamed skin: role for tissue microenvironment and dendritic cells in establishment of T cell-homing subsets. J. Immunol. 2004, 172:857-863.
35. Groves R.W., Allen M.H., Barker J.N., Haskard D.O., MacDonald D.M. Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br. J. Dermatol. 1991, 124:117-123.
36. Bhushan M., Bleiker T.O., Ballsdon A.E., Allen M.H., Sopwith M., Robinson M.K., Clarke C., Weller R.P., Graham-Brown R.A., Keefe M., Barker J.N., Griffiths C.E. Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial. Br. J. Dermatol. 2002, 146:824-831.
37. Fujita T., Fujimoto M., Matsushita T., Shimada Y., Hasegawa M., Kuwano Y., Ogawa F., Takehara K., Sato S. Phase-dependent roles of E-selectin during chronic contact hypersensitivity responses. Am. J. Pathol. 2007, 170:1649-1658.
38. Friedrich M., Bock D., Philipp S., Ludwig N., Sabat R., Wolk K., Schroeter-Maas S., Aydt E., Kang S., Dam T.N., Zahlten R., Sterry W., Wolff G. Pan-selectin antagonism improves psoriasis manifestation in mice and man. Arch. Dermatol. Res. 2006, 297:345-351.
39. Jung U., Norman K.E., Scharffetter-Kochanek K., Beaudet A.L., Ley K. Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo. J. Clin. Invest. 1998, 102:1526-1533.
40. Dunne J.L., Ballantyne C.M., Beaudet A.L., Ley K. Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood 2002, 99:336-341.
41. Leonardi C.L., Kimball A.B., Papp K.A., Yeilding N., Guzzo C., Wang Y., Li S., Dooley L.T., Gordon K.B. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 2008, 371:1665-1674.
42. Papp K.A., Leonardi C., Menter A., Ortonne J.P., Krueger J.G., Kricorian G., Aras G., Li J., Russell C.B., Thompson E.H., Baumgartner S. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 2012, 366:1181-1189.
43. Boyman O., Hefti H.P., Conrad C., Nickoloff B.J., Suter M., Nestle F.O. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J. Exp. Med. 2004, 199:731-736.
44. Kamata M., Tada Y., Mitsui A., Shibata S., Miyagaki T., Asano Y., Sugaya M., Kadono T., Sato S. ICAM-1 deficiency exacerbates sarcoid-like granulomatosis induced by Propionibacterium acnes through impaired IL-10 production by regulatory T cells. Am. J. Pathol. 2013, 183:1731-1739.
45. Nummer D., Suri-Payer E., Schmitz-Winnenthal H., Bonertz A., Galindo L., Antolovich D., Koch M., Buchler M., Weitz J., Schirrmacher V., Beckhove P. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma. J. Natl. Cancer Inst. 2007, 99:1188-1199.
46. Wohler J., Bullard D., Schoeb T., Barnum S. LFA-1 is critical for regulatory T cell homeostasis and function. Mol. Immunol. 2009, 46:2424-2428.
47. Ruth J.H., Amin M.A., Woods J.M., He X., Samuel S., Yi N., Haas C.S., Koch A.E., Bullard D.C. Accelerated development of arthritis in mice lacking endothelial selectins. Arthritis Res. Ther. 2005, 7:R959-R970.
48. Bullard D.C. Adhesion molecules in inflammatory diseases: insights from knockout mice. Immunol. Res. 2002, 26:27-33.